Our findings revealed that the pharmacological suppression of PD-L1 or the PI3K-AKT-mTOR pathway, alone (Fig. 7a, b) or in combination (Fig. 7c), significantly suppressed the formation and expansion of organoids derived from AM patients. The gene discussed is MTOR; the disease is acute myeloblastic leukemia with maturation.